Discover 212 paid clinical trials in Meridian, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Meridian is home to a wide range of active clinical trials focusing on conditions such as diabetes, chronic pain management, and mental health research. Participants in these trials gain access to the latest healthcare innovations while helping shape the future of medical treatments. The city's leading research institutions offer numerous opportunities for both healthy volunteers interested in paid trials and individuals looking for studies targeting specific conditions.
Filter
2
Filter results
Results: 212
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
for
Irritable Bowel Syndrome
Location: Meridian ID, Missoula MT, Ogden UT, Sandy City UT,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07519395
Phase2, Recruiting
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
for
Uterine Fibroids, Endometriosis
Location: Meridian ID, Idaho Falls ID, Salt Lake City UT,
Sponsor: Sumitomo Pharma Switzerland GmbH
Sex: Female
Age: 18 - 50
Code: NCT05862272
Phase3, Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for
Alzheimer Disease, Dementia, Plaque, Amyloid
Location: Boise ID, Tacoma WA, Bellevue WA, Sacramento CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 55+
Code: NCT07602582
Phase3, Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
for
Migraine
Location: Boise ID, Hawthorne CA, Grand Island NE, Sioux Falls SD,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT05156398
Phase3, Recruiting
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Nampa ID, Portland OR, Las Vegas NV, Duarte CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03739814
Phase2, Recruiting
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study